although valuat reflect elev expect believ
outperform street estim favor comp multitud growth driver
across busi unit make nice quarterli set-up see continu momentum
syk diversifi franchis reiter outperform rate rais
pt
easi comp product specif tailwind propel result
analyz tailwind headwind across busi unit see accompani slide
report believ sustain oper momentum deliv revenu
ep out-performance especi given softest organ ex-sel day comp year
deservedli assign premium multipl rel larg cap medic devic
peer thu continu momentum busi drive out-performance essenti
multipl expans result forecast revenu
organ slightli consensu estim ep
penni street project preview quarter see multipl
yoy sequenti tailwind benefit syk path toward exceed street
estim organ ex-sel day growth estim sequenti
acceler despit lower comp task deliv
organ growth comp
forecast organ growth orthoped benefit second
easiest comp year accolad hip launch full effect last
year estim organ growth medsurg benefit organ
contribut novadaq much anticip camera launch endoscopi
gener healthi end-market condit manag indic strong order
book across capit busi forecast neurotech spine organ growth
unit benefit continu strong neurovascular market trend light yoy spine
comp given soft market last year first full quarter entellu medic
organ contribut sonopet iq launch total believ enough
posit underli tailwind across busi unit drive top line beat
viabl path in-lin ep better
margin expans estim expans
expect ultim acceler margin expans back half year due
softer fx headwind lighter dilut hit annual expans target
opex ration continu execut ctg program part off-set
addit invest neg mix impact stronger growth capit busi
price pressur oper margin dilut primarili ep forecast
penni consensu estim
reiter outperform rate increas price target
ep blend ebitda
pleas see page report import disclosur
outperform rate center belief diversifi busi model margin
expans initi strategi off-set continu price util
headwind ortho spine market expect deliv top-tier top-
bottom-lin growth vs med tech peer thu justifi premium valuat multipl
importantli think well posit ou emerg market expans
china lead way also see double-digit growth potenti trauma
extrem line instrument neurovascular devic among product
market develop share gain
trevo follow recent releas
maintain share diversifi ortho
segment stabil spine
reduct cogs/year
 drive sale growth
irr year target close
better-than-expect ww share gain
ortho spine trauma busi
rapid expans better-than-
expect adopt emerg market
mark
ortho spine market worsen
share loss ortho spine mkt
portfolio outsid recon busi
fail provid suffici offset
ep growth fall short growth target
next five year
lead global medic technolog compani offer divers portfolio
reconstruct joint spine medic surgic neurovascular product compani
three major busi segment reconstruct medsurg neurotechnolog
spine product offer includ implant joint replac trauma spine-bas
surgeri surgic equip navig system endoscop commun
system patient handl emerg medic equip endovascular devic
treatment stroke coil treatment aneurysm major
global presenc look increas sale emerg market includ china
acquisit trauson acquisit mako surgic late brought
innov robot technolog platform recon busi earli
acquisit physio-control bolster medsurg busi
thomson one cowen compani compani file
thomson one cowen compani compani file
thomson one cowen compani compani file
cowen compani
thomson one cowen compani compani file
compani report thomson eikon cowen compani
select revenu metric mm cowen trauma incom statement mm except profit net per count cowen
compani report thomson eikon cowen compani
mm except ex-med devic gener oper profit net non-gaap net earn per non-gaap earn per earn per cowen
compani report cowen compani
growth currenc growth currenc growth currenc growth currenc state growth currenc growth currenc growth currenc growth growth currenc growth currenc state growth currenc growth currenc cowen
compani report cowen compani
growth currenc growth growth currenc growth currenc growth growth currenc growth currenc growth growth currenc growth currenc growth currenc growth currenc growth currenc growth currenc growth currenc cowen
compani report cowen compani
growth currenc growth currenc growth currenc growth currenc growth currenc growth currenc spine growth currenc growth growth growth currenc growth growth currenc inorgan sell day report growth report growth ex-inorgan sell organ growth organ growth ex-fx ex-sel cowen
valuat methodolog primarili base current year forward year ev/sal
ev/ebitda multipl well current year forward price-to-earnings multipl total return/p
ratio market cap/fre cash flow metric dividend yield comp
orthoped industri risk continu util pressur account
organ play bigger role health care deliveri competit dynam global
potenti regulatori delay reject failur devic clinic trial econom
sensit price pressur and/or weaken consum demand develop market
econom and/or polit uncertainti emerg market intellectu properti
deeper util pressur europ competit dynam global
potenti regulatori delay reject failur devic clinic trial econom
sensit price pressur and/or weaken demand develop market econom
and/or polit uncertainti emerg market fluctuat foreign exchang
